Future proof your HCP strategy. Four questions to help you decide if your HCP analysis data is ready for next phase approval.

Host cell proteins (HCPs) are a primary source of impurities in biologics development. Scientists must detect and remove HCPs to ensure patient safety and meet regulatory guidelines. If previously undetected HCPs are found in later phases of clinical
trials, scientists will need to redesign the drug substance purification strategy – adding financial and time costs that can create long project delays.

Find out if your HCP analysis data is ready for next phase approval using our online guide. From sample preparation to data analysis, each step affects the next – and ultimately, your results.